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Summary
Objective: As compared to knee chondrocytes (KC), talar chondrocytes (TC) have superior synthetic activity and increased resistance to cat-
abolic stimuli. We investigated whether these properties are maintained after TC are isolated and expanded in vitro.
Methods: Human TC and KC from 10 cadavers were expanded in monolayer and then cultured in pellets for 3 and 14 days or in hyaluronan
meshes (Hyaff-11) for 14 and 28 days. Resulting tissues were assessed biochemically, histologically, biomechanically and by real-time re-
verse transcriptase-polymerase chain reaction (RT-PCR). The proteoglycan and collagen synthesis rates in the pellets were also measured
following exposure to Interleukin-1 beta (IL-1b).
Results: After 14 days of pellet culture, TC and KC expressed similar levels of type I collagen (CI) and type II collagen (CII) mRNA and the
resulting tissues contained comparable amounts of glycosaminoglycans (GAG) and displayed similar staining intensities for CII. Also proteo-
glycan and collagen synthesis were similar in TC and KC pellets, and dropped to a comparable extent in response to IL-1b. Following 14 days
of culture in Hyaff-11, TC and KC generated tissues with similar amounts of GAG and CI and CII. After 28 days, KC deposited signiﬁcantly
larger fractions of GAG and CII than TC, although the trend was not reﬂected in the measured biomechanical properties.
Conclusion: After isolation from their original matrices and culture expansion, TC and KC displayed similar biosynthetic activities, even in the
presence of catabolic stimuli. These in vitro data suggest a possible equivalence of TC and KC as autologous cell sources for the repair of talar
cartilage lesions.
ª 2008 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Among the many surgical options for the treatment of
symptomatic chondral and osteochondral lesions of the ta-
lus in the ankle joint1, implantation of autologous chondro-
cytes is gaining increasing popularity, especially for
critically sized defects1,2,3. For direct or matrix-associated
autologous chondrocyte implantation (ACI) in the talar car-
tilage, cells are typically harvested from a low weight bear-
ing area of the ipsilateral knee joint, since it is easier
accessible and can guarantee larger size biopsy as com-
pared to the affected ankle joint2,3,4,5. On the otheraBoth authors contributed equally.
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489hand, following substantiated considerations related to
cell density in ankle cartilage and to the still controversial
issue of morbidity at the harvest site in the knee, Matricali
et al. proposed that ‘‘the ankle should not be excluded
a priori as a possible biopsy site’’ for chondrocyte isola-
tion6. The authors further indicated that ankle cartilage
specimens could be harvested arthroscopically at the post-
eromedial rim of the talar bone. The use of talar chondro-
cytes (TC) instead of knee chondrocytes (KC), which was
introduced in a recent clinical study4, would also be sup-
ported by the potential advantage of deriving from a joint
which is less susceptible than the knee to degenerative
processes and has greater capacity for repair in response
to damage7. Indeed, there is a general consensus on the
fact that e as compared to KC e TC have higher synthe-
sis rates of cartilaginous matrix proteins7,8,9, as well as the
capacity to organize a denser extracellular matrix, provid-
ing an increased resistance to loading and decreased sen-
sitivity to mechanical damage10.
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need to be isolated from their own microenvironment and
expanded in vitro, which is typically associated with cell de-
differentiation and loss of the original chondrocyte pheno-
type11,12. Thus, in order to advocate potential biological
advantages in the use of TC as compared to KC as a source
for autologous cell-based talar cartilage repair, it is neces-
sary to assess whether following dedifferentiation TC and
KC will retain the differences in biosynthetic activity dis-
played in the native tissue. So far, to the best of our knowl-
edge, only two studies have compared isolated TC and KC,
with controversial ﬁndings. Huch et al. reported that TC, fol-
lowing isolation and culture in alginate beads, maintained
a higher synthetic activity as compared to KC9, whereas
Aurich et al., using the same culture system, found that iso-
lated TC and KC displayed similar rates of glycosaminogly-
can synthesis13. Importantly, both studies have been limited
to the use of freshly harvested chondrocytes, and thus do
not provide an indication on the biosynthetic activity and
chondrogenic capacity of the cells following culture expan-
sion, which would be relevant in the context of ACI
procedures.
In the present study, we aimed at comparing TC and KC
with respect to features which could have a direct implica-
tion for cell-based cartilage repair procedures, for which
an in vitro cell expansion phase is required. Thus, we inves-
tigated their proliferation rate and post-expansion biosyn-
thetic activity, capacity to generate cartilaginous tissues
and response to Interleukin-1 beta (IL-1b), a catabolic factor
normally present in injured joints. For this purpose, consid-
ering the typically large inter-individual variability in chon-
drocyte function14, TC and KC were isolated from different
sites of the same individuals. Cells were expanded in mono-
layers and transferred to different 3D systems which have
previously been used as standard models to investigate
chondrocyte re-differentiation and synthesis of cartilage-
speciﬁc extracellular matrix proteins, namely culture in mi-
cromass pellets and into 3D porous scaffolds.Materials and methodsCARTILAGE BIOPSIES, CHONDROCYTE ISOLATION AND
EXPANSIONAdult human TC and KC were collected post mortem from full-thickness
biopsies of the femoral condyle or of the talus of 10 individuals (mean age:
55 years, range 32e79 years) without macroscopic signs of arthritis, follow-
ing informed consent by relatives and in accordance with the Local Ethical
Committee. Cartilage tissues were weighed, minced in small pieces and di-
gested with 0.15% type II collagenase (10 mL solution/g tissue) for 22 h. The
isolated chondrocytes were expanded for two passages with Dulbecco’s Ea-
gle’s Medium (DMEM) containing 4.5 mg/mL D-glucose, 0.1 mM nonessen-
tial amino acids, 1 mM sodium pyruvate, 100 mM HEPES buffer, 100 U/mL
penicillin, 100 mg/mL streptomycin and 0.29 mg/mL L-glutamate and supple-
mented with 10% of foetal bovine serum (complete medium-CM), and 1 ng/
mL of Transforming Growth Factor b1 (TGFb1), 5 ng/mL of Fibroblast Growth
Factor 2 (FGF-2), and 10 ng/mL of Platelet-Derived Growth Factor type BB
(PDGF-BB) (all from R&D Systems, 6 Minneapolis, MN), as previously de-
scribed15. Chondrocytes were subsequently cultivated in pellets or in 3D
scaffolds as described below.PELLET CULTUREThe chondrogenic capacity of post-expanded human TC and KC was in-
vestigated using a simple and broadly used model, namely pellet cultures in
a deﬁned serum-free medium15. Brieﬂy, TC and KC were suspended in
DMEM supplemented with ITSþ 1 (Sigma Chemical, St. Louis, MO),
0.1 mM ascorbic acid 2-phosphate, 1.25 mg/mL human serum albumin,
107 M dexamethasone and 10 ng/mL TGFb1. Aliquots of 5 105 cells/
0.5 mL were centrifuged at 1000 rpm for 2 min in 1.5 mL polypropylene con-
ical tubes (Sarstedt, Nu¨mbrecht, Germany) to form spherical pellets, which
were placed onto a 3D orbital shaker (Bioblock Scientiﬁc, Frenkendorf,Switzerland) at 30 rpm. Pellets were cultured for 3 or 14 days, with medium
changes twice per week, and subsequently processed for histological, immu-
nohistochemical, biochemical and mRNA analysis, as well as for the proteo-
glycan and collagen synthesis, as described below. In some experiments,
pellets generated by TC and KC from three donors were also exposed to
1 ng/mL human recombinant IL-1b (Roche Diagnostics GmbH, Mannheim,
Germany) for the last 72 h. The IL-1b concentration was selected based
on preliminary studies from a range of 0.05e10 ng/mL, as the one inducing
a visible and reproducible loss of accumulated glycosaminoglycans (GAG) in
the pellets, up to about 50% of the controls. Each analysis was performed
independently in at least two entire pellets for each primary culture.CULTURE ON POROUS 3D SCAFFOLDSThe ability of expanded human TC and KC to generate neo-cartilage was
also investigated by cultures in esteriﬁed hyaluronic acid non-woven meshes
(Hyaff-11, Fidia Advanced Biopolymers, Abano Terme, IT), since (1) the
system was previously described as a reliable model for chondrocyte re-dif-
ferentiation16, (2) the model allows more extensive cartilaginous tissue mat-
uration than in pellets over prolonged culture times17 and (3) the resulting
cell-scaffold constructs are currently in clinical use for cartilage repair18.
Chondrocytes were loaded statically on the scaffolds (6 mm diameter,
2 mm thick disks) at a density of 4 106 cells/scaffold. Cell-scaffold con-
structs were cultured in CM supplemented with 0.1 mM ascorbic acid,
10 mg/mL Insulin and 10 ng/mL Transforming Growth Factor-b3, TGFb3,
with medium changes twice a week, as previously described19. After 14 or
28 days of static culture, the resulting Engineered Cartilage generated by Ta-
lar chondrocytes (ECT) and Engineered Cartilage generated by Knee chon-
drocytes (ECK) were analysed histologically, immunohistochemically,
biochemically and biomechanically, as described below.MEASUREMENT OF [35S]SO4 AND [
3H]PROLINE
INCORPORATIONThe proteoglycan and collagen synthesis of the cultured pellets was mea-
sured by assessing the incorporation of [35S]SO4 and [
3H]proline for a period
of 24 h as described previously20. After 3 or 14 days of culture, pellets were in-
cubated in the presence of both [35S]SO4 (1 mCi/culture) to label proteoglycans
and [3H]proline (1.5 mCi/culture) to label collagen. Since synthesized extracel-
lular matrix (ECM) components can either be incorporated into the culture or
released to the media, matrix synthesis was determined by measuring both
fractions. For the assessment of the released ECM fraction, radiolabeled pro-
teoglycan and collagenwere precipitated overnight at 4 Cusing, respectively,
100% ethanol and 70% ammonium sulfate. Subsequently, samples were
centrifuged at 14,000 rpm for 30 min and the pellets resuspended in 4 M gua-
nidine hydrochloride or 10% sodium dodecyl sulfate in Tris buffer (0.1 M, pH
7.0), respectively, for proteoglycan and collagen. For the assessment of the in-
corporated ECM fraction, tissue pellets were gently washed three times with
phosphate buffered saline (PBS) to remove the unincorporated isotopes. Pel-
lets were then digested for 15 h at 56 C with protease K (0.5 mL of 1 mg/mL
protease K in 50 mM Tris with 1 mM ethylenediaminetetraacetic acid
(EDTA), 1 mM iodoacetamideand10 mg/mLpepstatin-A, respectively). The in-
corporation of [35S]SO4 and [
3H]proline in culture pellet and in conditioned me-
dium was measured in a Packard b-liquid scintillation counter with scintillation
ﬂuid (Ultima Gold, Perkin Elmer). The amount of synthesized molecules was
calculated relative to the DNA content of the tissue. For this analysis cells
from three donors were used, with triplicate pellets for each condition.BIOCHEMICAL ANALYSESECT and ECK were lyophilized and weighed. Pellets of TC and KC, ECT
and ECK were then digested with protease K (0.5 mL and 1 mL of solution,
respectively, for pellets and scaffold-based constructs) as indicated above.
GAG amounts were measured spectrophotometrically after reaction with di-
methylmethylene blue21, with chondroitin sulfate as a standard. DNA was
measured spectroﬂuorometrically using the CyQuant cell proliferation assay
Kit (Molecular Probes, Eugene, OR), with calf thymus DNA as a standard22.
GAG contents were reported as % GAG/dry weight tissue (for ECT and ECK)
or GAG/DNA (for pellets).
For the determination of type I collagen (CI) and II collagen (CII), constructs
were lyophilized. The dried samples were fully solubilised by digestion with
2 mg/mL Tosylamide-2-phenylethyl chloromethyl ketone-treated bovine pan-
creatic trypsin in 50 mM TriseHCl, pH 7.6, containing 1 mM iodoacetamide,
1 mM EDTA and 10 mg/mL pepstatin-A, using an initial incubation of 15 h at
37 C followed by a further 2 h incubation at 65 C after the addition of fresh
trypsin. Samples were boiled for 15 min to inactivate the enzyme23. Amounts
of CII were assayed by inhibition enzyme-linked immunosorbent assay
(ELISA) using a mouse IgGmonoclonal antibody to denatured CII24. Amounts
of CI were assayed by inhibition enzyme-linked immunosorbent assay
(ELISA) using a rabbit anti-peptide antibody to CI23.
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POLYMERASE CHAIN REACTION (RT-PCR) ASSAYSRNA of pellets for TC and KC was extracted using Trizol (Life Technolo-
gies, Basel, Switzerland), according to the Manufacturer’s protocol. Pellets
cultured in chondrogenic medium were ﬁrst sonicated for 1 min while in Tri-
zol. RNA was treated with DNAseI using the DNA-freeTM Kit (Ambion, USA)
and quantiﬁed spectroﬂuorimetrically. cDNA was generated from 3 mg of
RNA by using 500 mg/mL random hexamers (Catalys AG, CH) and 1 mL of
50 U/mL StratascriptTM reverse transcriptase (Stratagene, NL), in the pres-
ence of dNTPs. PCR reactions were performed and monitored using the ABI
Prism 7700 Sequence Detection System (Perkin-Elmer/Applied Biosystems,
Rotkreuz, Switzerland). Cycle temperatures and times as well as primers
and probes used for the reference gene (18-S rRNA) and the genes of inter-
est (CI and CII), were as previously described15. For each cDNA sample, the
threshold cycle (Ct) value of 18-S was subtracted from the Ct value of the
target gene, to derive DCt. The level of expression of CI and CII was calcu-
lated as 2DCt. Each sample was assessed at least in duplicate for each gene
of interest.HISTOLOGICAL AND IMMUNOHISTOCHEMICAL ANALYSESGenerated pellets and constructs were rinsed with PBS, ﬁxed in 4% for-
malin, embedded in parafﬁn, and cross-sectioned (5 mm thick for pellets
and 7 mm thick for constructs). Sections were stained with Safranin O for sul-
fated GAG.
Sections were processed for immunohistochemistry using an antibody
against CI (II-II6B3, Hybridoma Bank, University of Iowa, USA), as previously
described25.BIOMECHANICAL ANALYSISMechanical tests on constructs were conducted in a standard miniature
test instrument in unconﬁned compression (Synergie 100, MTS Systems
Corp., Eden Prairie MN, USA) to measure the Equilibrium modulus (EEQ)
and the Pulsatile dynamic modulus (EPD), as previously described in detail
19.
Brieﬂy, EEQ was determined from a linear regression of the data pairs of equi-
librium stress/incremental strain, following application of ﬁve incremental
strains of 5% and computation of the corresponding equilibrium stress.
EPD was calculated as the slope of the stress/strain curve, after exposing
specimens to ﬁve cycles of compressive loading/unloading at 0.17 mm/s,
reaching a strain of 20% and with each strain period followed by a no-load
period of time equal to that for loading/unloading.STATISTICAL ANALYSISUnless otherwise stated, values are presented as mean standard error
of measurements from 10 independent experiments, using cells from 10Fig. 1. Histological properties of TC and KC pellets after 2 weeks of cultu
resentative pellets generated by TC and KC from the same donors andonors. Statistical analyses were performed using the Sigma Stat software
(SPSS Inc., Version13). Differences among experimental groups in the com-
parison between TC and KC were assessed by two tailed Wilcoxon test, and
considered statistically signiﬁcant with P< 0.05.ResultsPROLIFERATION RATE OF HUMAN TALAR AND KNEE
CHONDROCYTESAlthough native ankle cartilage has been reported to
have a higher cellularity than knee cartilage7,10,26, we found
no signiﬁcant difference between the cell yields of native
cartilage harvested from the talus or the femoral condyle
of the same individuals (3.3 0.68 106 and 3.6  0.45
106 cells/g tissue, respectively). It is possible that other
factors beyond the tissue cellularity (e.g., efﬁciency of cell
extraction from the extracellular matrix, or survival capacity
of the cells during enzymatic treatment) might have
accounted for our ﬁnding.
In the time required to reach the second conﬂuence (i.e.,
13e19 days), TC and KC displayed similar proliferation
rates (0.55 0.05 and 0.58 0.03 doublings/day, respec-
tively) and underwent a similar number of doublings
(7.7 0.5 and 8.0 0.2, respectively). At the end of the
expansion phase, both TC and KC exhibited an elongated
ﬁbroblastic morphology, characteristic of de-differentiated
chondrocytes (data not shown).POST-EXPANSION CHONDROGENIC CAPACITY IN PELLETSAccumulation of cartilage-specific proteins
After 14 days of culture, expanded TC and KC gener-
ated hyaline-like cartilaginous tissues, with similar staining
intensity for GAG and CII in pellet pairs generated by the
cells from the same donors (Fig. 1). Biochemical analysis
quantitatively conﬁrmed that pellets generated by TC con-
tained GAG/DNA contents similar to those generated by
KC (13.9 3.2 and 12.1 1.6 mg/mg, respectively)
(Fig. 2A). RT-PCR analysis further characterized that CI
and CII mRNA expression was comparable in pelletsre. (AeB) Safranin O and CII immunohistochemical staining of rep-
d cultured for 2 weeks in chondrogenic medium. Bar¼ 100 mm.
492 C. Candrian et al.: Human knee and talar chondrocytes comparisongenerated by TC and KC (Fig. 2B). The relatively high
expression of CI is rather typical for chondrocytes cul-
tured in this model for 2 weeks and should not be attrib-
uted to an unsuccessful cell re-differentiation, since the
ratio of CI/CII mRNA expression of post-expanded chon-
drocytes has previously been shown to strongly decrease
following pellet culture27,28.
Synthesis of cartilage-specific proteins
Proteoglycan and collagen synthesis increased between
3 and 14 days of pellet culture to a similar extent for TC
(6.4- and 1.5-fold, respectively) and KC (7.8- and 1.2-fold,
respectively), remaining at comparable levels (Fig. 2C and
D). The released fractions of proteoglycan and collagen
were rather limited, averaging less than 5% of the total
amount of the newly synthesized molecules.
Response to IL-1b
Pellets at different stages of maturation (i.e., after 3 and
14 days of culture) were exposed to IL-1b for 72 h. In 3-
day pellets, for both TC and KC, IL-1b treatment resulted
in extensive tissue degeneration, as evidenced histologi-
cally by the reduction of extracellular matrix and the appear-
ance of necrotic cells (Fig. 3A), as well as biochemically by
the reduced amounts of GAG and synthesis of proteoglycan
and collagen, down to the minimal levels of detection
(Fig. 3BeD). In 14-day pellets generated by both TC and
KC, the exposure to IL-1b resulted in loss of cartilaginous
matrix, as evidenced histologically by a reduced Safranin
O staining intensity, as well as biochemically by a statisti-
cally signiﬁcant reduction of GAG contents (1.9- and
1.6-fold, respectively), synthesis of proteoglycans (7.0-
and 16.0-fold, respectively) and synthesis of collagens
(4.2- and 3.7-fold, respectively) (Fig. 4). Importantly, TC0.0
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Fig. 2. Biosynthetic activity of TC and KC pellets after 2 weeks of culture.
DNA. (B) Real-time reverse transcriptase-polymerase chain reaction ana
S.E.M. of measurements obtained from 10 independent experiments. N
measured by the incorporation of, respectively, [3H]proline and [35S]SO4 in
parts of the columns are related, respectively, to the newly synthesized m
matrix. Values are mean S.E.M. of measurements obtained from three i
time point of the samand KC pellets reacted in an almost identical fashion and
extent to IL-1b, at both stages of maturation.POST-EXPANSION CHONDROGENIC CAPACITY
IN 3D SCAFFOLDSAfter 14 days of culture in Hyaff-11 meshes, the result-
ing engineered cartilage generated by talar chondrocytes
(ECT) and engineered cartilage generated by knee chon-
drocytes (ECK) were only faintly stained for GAG and CII
(data not shown). Instead, after 28 days of culture, ECT
and ECK displayed regions intensely stained for GAG and
CII. At this stage, ECT appeared to be stained at lower in-
tensity and uniformity for both extracellular matrix proteins
as compared to ECK (Fig. 4).
Biochemical analysis generally conﬁrmed the histological
observations. Following 14 days of culture, similar GAG, CI
and CII contents were measured in ECT and ECK (Fig. 5A).
The increase in the GAG content as a % of dry weight from
14 to 28 days of culture was larger for ECK than ECT (2.6-
and 1.8-fold, respectively), resulting in signiﬁcantly higher ﬁ-
nal GAG contents (1.6-fold) in tissues formed by KC
(Fig. 5A). Interestingly, CII content did not increase with cul-
ture time in ECT, whereas it increased by 2.2-fold in ECK,
resulting in double amounts in ECK than in ECT (Fig. 5A).
Between 14 and 28 days of culture, CI content increased
to a similar extent in ECK and ECT, reaching similar levels
at the latest time point (Fig. 5A). At 28 days, the CII/CI ratio
was 0.39 0.16 and 0.92 0.26, respectively, in ECT and
ECK, indicating a more ﬁbrocartilaginous nature of the tis-
sues generated by TC.
Interestingly, the measured biomechanical properties of
tissues did not capture the biochemical differences
(Fig. 5B). In fact, equilibrium modulus (EEQ) and dynamic
pulsatile modulus (Edyn) were comparable in ECT and
ECK at 2 weeks culture, signiﬁcantly increased between1.0E-04
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Fig. 3. Respose to IL-1b by tissues generated by TC and KC at different stages of maturation. (A) Safranin O stainings of representative pellets
generated by TC and KC from the same donors. Bars¼ 100 mm. (B) Sulfate glycosaminoglycan content normalized to the amount of DNA in
pellets maintained in culture for a total of 14 days where the last 72 h with (IL-1) or without control (CTR) IL-1b. Newly synthesized amounts of
collagen (C) and proteoglycan (D), measured by the incorporation of, respectively, [3H]proline and [35S]SO4, in pellets maintained in culture 14
days. The upper and lower parts of the columns are related, respectively, to the newly synthesized molecules released in the medium or ac-
cumulated in the extracellular matrix. Values are mean  S.E.M. of measurements obtained from three independent experiments.
*¼ signiﬁcantly different from CTR.
493Osteoarthritis and Cartilage Vol. 17, No. 414 and 28 days of culture to a similar extent in ECT and
ECK (EEQ: 1.8- and 1.9-fold, Edyn: 1.9- and 1.4- fold, re-
spectively) and thus reached similar levels at the end of
the culture.Discussion
In this study we compared proliferation capacity, post-ex-
pansion biosynthetic activity, chondrogenic ability and re-
sponse to the catabolic factor IL-1b of human TC and KC
from the same individuals. Cells isolated from the different
cartilage tissues proliferated at a similar rate in monolayer
culture and, when induced to re-differentiate in 3D pellets,
synthesized and accumulated comparable amounts of
GAG and CII. Moreover, in response to IL-1b, TC and KC
cultured in pellets reduced synthesis and accumulation of
the main cartilage-speciﬁc macromolecules in a similar
fashion and extent. Finally, following culture for 28 days inHyaff-11 scaffolds, TC formed cartilaginous tissues with
lower GAG and CII contents as compared to KC, but with
similar biomechanical properties.
Although in the present study the behaviour of chondro-
cytes from native talar and knee cartilage tissues was not
investigated, other groups previously reported that primary,
non-expanded TC have a higher proteoglycan7,8 and colla-
gen synthesis9 than KC, as well as a superior resistance to
the catabolic cytokine IL-1b8,13. Together with those ﬁnd-
ings, our results (1) indicate that such differences are
lost when chondrocytes, isolated from their original matri-
ces, are de-differentiated by expansion and subsequently
induced to re-differentiate in pellet cultures, and (2) sug-
gest a potential critical role of the native tissue environ-
ment (e.g., composition and organization of the
extracellular or pericellular matrix) in determining the prop-
erties of KC or TC.
The capacity of de-differentiated TC and KC to generate
3D cartilaginous tissues was also tested in non-woven
Fig. 4. Histological properties of the engineered cartilaginous tissues generated by talar chondrocytes and knee chondrocytes after 4 weeks of
static culture. (AeB) Safranin O and CII immunohistochemical stainings of representative ECT or ECK. Bar¼ 100 mm.
494 C. Candrian et al.: Human knee and talar chondrocytes comparisonmeshes made of esteriﬁed hyaluronic acid (Hyaff-11),
a model allowing more extensive tissue maturation than pel-
lets17. Contrarily to the results obtained in pellets, KC cul-
tured in such scaffolds accumulated superior amounts of
GAG and CII than TC. Since this difference was not ob-
served after 14 days in culture and appeared only after 28
days, the apparent discrepancy could highlight that e asECT
ECT
0.0
5.0
10.0
15.0
20.0
2 weeks 4 weeks
GAG
%
 
d
r
y
 
w
e
i
g
h
t
*
*°
A
B
0.0
2.0
4.0
6.0
2 weeks
Type II 
%
 
d
r
y
 
w
e
i
g
h
t
Matrix acc
Biomechanic
0
10
20
30
40
2 weeks 4 weeks
K
P
a
*
*
Equilibrium modulus
Fig. 5. Biosynthetic activity and biomechanical properties of engineered ca
tilage generated by knee chondrocytes (ECK) after 2 and 4 weeks of stati
as a percentage of tissue dry weight. (B) Equilibrium modulus and dynam
indicates the biomechanical properties of the cell-free Hyaff-11 scaffold.
pendent experiments. *¼ signiﬁcantly different from the earlier time pocompared to KC e expanded TC have an impaired
capacity of extensive maturation, which cannot be discrim-
inated in the pellet culture system. Considering the higher
cell-to-cell contacts in pellets as compared to the scaffold-
based cultures, the superior deposition of cartilage-speciﬁc
proteins by KC as compared to TC in Hyaff-11 meshes
could alternatively be due to the fact that chondrogenesisECK
ECK
4 weeks
collagen
*°
0.0
2.0
4.0
6.0
2 weeks 4 weeks
Type I collagen
%
 
d
r
y
 
w
e
i
g
h
t
*
*
umulation
al properties
0.0
0.5
1.0
1.5
2.0
2 weeks 4 weeks
M
P
a
* *
Dynamic pulsatile modulus
rtilage generated by talar chondrocytes (ECT) and engineered car-
c culture. (A) Amounts of GAG, CI and CII accumulated, expressed
ic pulsatile modulus of ECT and ECK constructs. The plotted line
Values are mean S.E.M. of measurements obtained from 10 inde-
int of the same cell source; B¼ signiﬁcantly different from ECT.
495Osteoarthritis and Cartilage Vol. 17, No. 4of KC is less cell density-dependent. Yet another explana-
tion could be related to the inﬂuence on KC by the Hy-
aff-11 mesh properties, which have been previously
reported to speciﬁcally modulate certain KC functions
(e.g., the down-regulation of some catabolic factors in-
volved in cartilage degeneration29).
It is necessary to point out that in our experiments we
compared TC and KC from healthy cadaveric joints. A sim-
ilar investigation using TC and KC derived from biopsies of
traumatic joints of patients would be more relevant for a tar-
get clinical application. In this regard, it should be consid-
ered that (1) in focally damaged ankle cartilage, an
upregulation of matrix turnover was observed also at sites
remote from the lesion30, which was not seen for the knee
cartilage31; and that (2) chondrocytes derived from the le-
sioned ankle cartilage have been proposed as a valid cell
source in the treatment of cartilage defects in the talus32.
We are also aware that the models used in the present
study to characterize the post-expansion chondrogenic ca-
pacity of the TC and KC (i.e., static culture in the presence
of chondrogenic factors), have not been validated to directly
predict the reparative ability of the cell types when im-
planted in the talar lesions. In the absence of an orthotopic
model where to test the performance of human chondro-
cytes for cartilage repair beyond the patient, further studies
may investigate the matrix synthesis/production of ex-
panded TC and KC under conditions better resembling
the injured joint (e.g., with application of mechanical loading
in the presence of pro-inﬂammatory/catabolic mediators).
In conclusion, our ﬁndings indicate that differences be-
tween human TC and KC observed when cells are in their
original environments are not anymore detectable following
monolayer expansion. Together with the recent evidences
on the ability of expanded nasal19 and auricular chondro-
cytes33 to adapt to new environments, this study thus under-
lines the concept of extensive plasticity of chondrocytes
following dedifferentiation15. Moreover, from a clinical stand-
point, despite the convincing body of literature on the meta-
bolic, biochemical and biomechanical differences between
talar and knee cartilage tissues, our results indicate a possi-
ble equivalence of TC and KC as autologous cell sources for
the repair of cartilage lesions of the talus.Conﬂict of interest
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